Literature DB >> 26689301

International rare donor panels: a review.

S Nance1, E A Scharberg2, N Thornton3, V Yahalom4, I Sareneva5, C Lomas-Francis6.   

Abstract

International rare blood donor panels or registries are important in the consistent availability of rare blood for patients who need this scarce resource. In countries where it has been possible to commit resources to this effort and often where the need is great, donors have been entered into a registry. The ISBT leadership recognized the importance of this very challenging inventory management activity and created a Working Party to support it. Individual countries support the WHO International Rare Donor Panel by submitting their donors' phenotype or genotype information to be catalogued into the database. It is extremely important that this database be cultivated and grown. The contributing countries keep their list updated and supply the blood product as they can when requested. It is known that some blood types are extremely scarce worldwide and requests for these are particularly difficult to fulfil. Thus, it is important to have a protocol to identify and recruit donors with rare blood types. It is equally or perhaps more important to ensure that the patients who need the rare blood are being managed appropriately in the presence and absence of rare blood products being available.
© 2015 International Society of Blood Transfusion.

Entities:  

Keywords:  IBGRL; ISBT; WHO international rare donor panel; international collaboration; rare donor programmes; rare donors

Mesh:

Substances:

Year:  2015        PMID: 26689301     DOI: 10.1111/vox.12357

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Authors:  Brigitte Katharina Flesch; Vanessa Scherer; Burkhard Just; Andreas Opitz; Oswin Ochmann; Anne Janson; Monika Steitz; Thomas Zeiler
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

2.  Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing.

Authors:  Joseph Hawksworth; Timothy J Satchwell; Marjolein Meinders; Deborah E Daniels; Fiona Regan; Nicole M Thornton; Marieangela C Wilson; Johannes Gg Dobbe; Geert J Streekstra; Kongtana Trakarnsanga; Kate J Heesom; David J Anstee; Jan Frayne; Ashley M Toye
Journal:  EMBO Mol Med       Date:  2018-06       Impact factor: 12.137

Review 3.  Blood Group Testing.

Authors:  Hong-Yang Li; Kai Guo
Journal:  Front Med (Lausanne)       Date:  2022-02-11

4.  Low-Frequency Blood Group Antigens in Switzerland.

Authors:  Christoph Gassner; Frauke Degenhardt; Stefan Meyer; Caren Vollmert; Nadine Trost; Kathrin Neuenschwander; Yvonne Merki; Claudia Portmann; Sonja Sigurdardottir; Antigoni Zorbas; Charlotte Engström; Jochen Gottschalk; Soraya Amar El Dusouqui; Sophie Waldvogel-Abramovski; Emmanuel Rigal; Jean-Daniel Tissot; Caroline Tinguely; Simon M Mauvais; Amira Sarraj; Daniel Bessero; Michele Stalder; Laura Infanti; Andreas Buser; Jörg Sigle; Tina Weingand; Damiano Castelli; Monica C Braisch; Jutta Thierbach; Sonja Heer; Thomas Schulzki; Michael Krawczak; Andre Franke; Beat M Frey
Journal:  Transfus Med Hemother       Date:  2018-07-10       Impact factor: 3.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.